Literature DB >> 23722008

Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer.

B Turkbey1, E Mena, O Aras, B Garvey, K Grant, P L Choyke.   

Abstract

Prostate cancer is currently the most common solid organ cancer type among men in the Western world. Currently, all decision-making algorithms and nomograms rely on demographics, clinicopathological data and symptoms. Such an approach can easily miss significant cancers while detecting many insignificant cancers. In this review, novel functional and molecular imaging techniques used in the diagnosis and staging of localised prostate cancer and their effect on treatment decisions are discussed. Published by Elsevier Ltd.

Entities:  

Keywords:  Localization; MRI; PET/CT; prostate cancer; staging

Mesh：

Year:  2013        PMID： 23722008      PMCID： PMC6330112          DOI： 10.1016/j.clon.2013.05.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


  8 in total

1.  Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.

Authors:  Xueming Wu; Guanping Yu; Daniel Lindner; Susann M Brady-Kalnay; Qi Zhang; Zheng-Rong Lu
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-07-15

Review 2.  Prognostic Utility of PET in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  PET Clin       Date:  2015-01-22

3.  Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?

Authors:  Silva Guljaš; Mirta Benšić; Zdravka Krivdić Dupan; Oliver Pavlović; Vinko Krajina; Deni Pavoković; Petra Šmit Takač; Matija Hranić; Tamer Salha
Journal:  Tomography       Date:  2022-06-09

4.  Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.

Authors:  Oluwaseun A Odewole; Funmilayo I Tade; Peter T Nieh; Bital Savir-Baruch; Ashesh B Jani; Viraj A Master; Peter J Rossi; Raghuveer K Halkar; Adeboye O Osunkoya; Oladunni Akin-Akintayo; Chao Zhang; Zhengjia Chen; Mark M Goodman; David M Schuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-18       Impact factor: 9.236

5.  Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.

Authors:  Yajuan Li; Zheng Han; Sarah Roelle; Aidan DeSanto; Rob Sabatelle; Rebecca Schur; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2017-10-25       Impact factor: 4.939

6.  Quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients.

Authors:  Ali Sadeghi-Naini; Ervis Sofroni; Naum Papanicolau; Omar Falou; Linda Sugar; Gerard Morton; Martin J Yaffe; Robert Nam; Alireza Sadeghian; Michael C Kolios; Hans T Chung; Gregory J Czarnota
Journal:  Transl Oncol       Date:  2015-02       Impact factor: 4.243

7.  Whole prostate volume and shape changes with the use of an inflatable and flexible endorectal coil.

Authors:  Murat Osman; Haytham Shebel; Sandeep Sankineni; Marcelino L Bernardo; Dagane Daar; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey; Harsh K Agarwal
Journal:  Radiol Res Pract       Date:  2014-10-13

Review 8.  Ultrasound Elastography of the Prostate Using an Unconstrained Modulus Reconstruction Technique: A Pilot Clinical Study.

Authors:  Seyed Reza Mousavi; Hassan Rivaz; Gregory J Czarnota; Abbas Samani; Ali Sadeghi-Naini
Journal:  Transl Oncol       Date:  2017-07-20       Impact factor: 4.243
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.